Filing Flows › Rapid Micro Biosystems (RPID) › Q1 2026 › vs Q4 2025
Rapid Micro Biosystems (RPID) Q1 2026 vs Q4 2025 (quarter over quarter)
Rapid Micro Biosystems's revenue fell $3.3M (-29%) from $11.3M in Q4 2025 to $8.0M in Q1 2026. The biggest changes: Product −$3.7M (-40%); Service +$451K (+23%).
Rapid Micro Biosystems, Q1 2026: revenue $8.0M (+11% year over year), operating margin -173.1%, net loss $14.3M, operating cash flow −$15.1M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Product | $5.6M | $9.3M | −$3.7M | -40% |
| Service | $2.4M | $2.0M | $451K | +23% |
| Revenue | $8.0M | $11.3M | −$3.3M | -29% |
| Net loss | $14.3M | $12.5M | $1.8M | +14% |
| Costs & expenses | $22.3M | $23.8M | −$1.5M | -6% |
| Operating costs | $21.9M | $23.5M | −$1.6M | -7% |
| Interest & other, net | $415K | $272K | $143K | +53% |
| Income tax | $8K | $14K | −$6K | -43% |
| Research & development | $3.4M | $3.2M | $139K | +4% |
| Sales & marketing | $3.4M | $3.3M | $100K | +3% |
| General & admin | $7.4M | $5.3M | $2.1M | +39% |
| Operating cash sources | $17.0M | $4.7M | $12.3M | +264% |
| Depreciation & amortization | $706K | $790K | −$84K | -11% |
| Share-based compensation | $1.2M | $627K | $596K | +95% |
| Cash used in operations | $15.1M | $3.2M | $11.8M | +364% |
| Net loss absorbed | $14.3M | $12.5M | $1.8M | +14% |
| Working capital & other | $2.7M | −$7.8M | $10.5M | — |
Questions
How much did Rapid Micro Biosystems's revenue grow quarter over quarter in Q1 2026?
Rapid Micro Biosystems's revenue fell $3.3M (-29%) from $11.3M in Q4 2025 to $8.0M in Q1 2026.
What drove Rapid Micro Biosystems's revenue change in Q1 2026?
Product −$3.7M (-40%); Service +$451K (+23%).